Certified by Founder Lodge
ProJenX
United States - New York, NY
START UP
1 Disclosed Funding Rounds $15,000,000
0 Participating Investments
-
Founded date
2021
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
ProJenX is a clinical-stage biotechnology company with novel, targeted, brain-penetrant therapies to address neurodegenerative diseases, with an initial focus on ALS. ProJenX was created out
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| November, 03 ,2023 | Series A | $15,000,000 |
Medical Excellence Capital, LLC
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Latent | $80,000,000 | (Mar 20, 2026)
PADO AI | $6,000,000 | (Mar 20, 2026)
games2gether | $5,202,945 | (Mar 20, 2026)
RunSybil | $40,000,000 | (Mar 20, 2026)
Avtal | $24,000,000 | (Mar 20, 2026)
